Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cytori initiates phase II cell therapy trial for knee osteoarthritis

Feb. 19, 2015

Novartis patent divulges PI3Kdelta/gamma inhibitors

Feb. 18, 2015

First clinical study of ONS-3010 meets primary endpoints

Feb. 13, 2015

Novo Nordkisk reports development of anti-uPA MAbs

Feb. 13, 2015

Anika Therapeutics files for U.S. and E.U. approval of Cingal for osteoarthritis of the knee

Feb. 12, 2015

FDA expands clearance for Nanotherapeutics bone filler to use in spinal fusion surgery

Feb. 11, 2015

Cadila Pharmaceuticals divulges agents for inflammation

Feb. 10, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

Proteostasis Therapeutics selects PTI-130 as a development candidate for CF

Feb. 6, 2015

Amgen releases topline results from phase III study of adalimumab biosimilar ABP-501

Feb. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.